| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2007;38:3117.)
© 2007 American Heart Association, Inc.
Editorials |
From the Stroke and Neurovascular Regulation Laboratory (M.A.M.), Department of Radiology Massachusetts General Hospital, Harvard Medical School, Charlestown, Mass; The Divisions of Aging and Preventive Medicine (T.K.), Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Mass; and the Department of Epidemiology (T.K.), Harvard School of Public Health, Boston, Mass.
Correspondence to Michael A. Moskowitz, MD, Stroke and Neurovascular Regulation Laboratory, Department of Radiology Massachusetts General Hospital, Harvard Medical School, Charlestown, Mass CNY 149-6403. E-mail moskowitz@helix.mgh.harvard.edu
Key Words: genetics migraine risk factors stroke
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
See related article, pages 3145–3151.
The relation between migraine and stroke has been well recognized and has been the focus of several publications.1–3 Despite many hypotheses linking the 2 disorders, the precise mechanisms are unknown, and not surprisingly very complex. In this issue of Stroke, Pezzini and colleagues4 add to this complexity by suggesting that migraine with aura may "mediate" the influence of specific genotypes on stroke risk. How might this interesting association come about biologically? At the present time, we dont know. Investigators believe that migraine is a complex genetic disorder5 in which multiple genes confer a small migraine risk burden together with a large impact from environmental events such as stress. However, genes responsible for causing common migraine subtypes such as migraine with and without aura are unknown as of this writing; therefore, it remains obscure whether a genetic component is involved in the link between migraine and stroke, and hence the study by Pezzini and colleagues is of particular interest.
The methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism constitutes an interesting target to further evaluate the biological link between migraine and stroke. MTHFR catalyzes the conversion of 5,10 methylene tetrahydrofolate into 5-methyl-tetrahydrofolate, the predominant form of folate within blood. Folate is used in multiple biochemical pathways including replication of DNA, metabolism of homocysteine as well as other methyl transfer reactions. The MTHFR C677T gene polymorphism has been associated with migraine with aura in some6,7 but not all studies8,9 and is associated with an increase
This article has been cited by other articles:
![]() |
M. E. Bigal, T. Kurth, H. Hu, N. Santanello, and R. B. Lipton Migraine and cardiovascular disease: Possible mechanisms of interaction Neurology, May 26, 2009; 72(21): 1864 - 1871. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |